Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastomaDeepak Rohila(University of California San Diego), Shweta Joshi(UC San Diego Health System)Frontiers in ImmunologyJune 7, 202310.3389/fimmu.2023.1148317Cited by 17SaveCiteExport RISWatch citationsRelated PapersSyk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma|Cancer Research|2023|42